Novellia Data Shown to Optimize Risk Profiling to Inform HER2+ Breast Cancer Care
-- New research demonstrates integrating AI-enabled, health record data insights with targeted educational interventions can enhance understanding and management of...
Month: December 2024
Myant to Reveal Award-Winning Health Platform Driven by Advanced Materials and AI at CES 2025
TORONTO, Dec. 12, 2024 /PRNewswire/ -- Myant Corp. announced it will unveil the future of human-AI interfaces at CES 2025,...
b.well Connected Health Names Sara Zywicki as Chief Product Officer
BALTIMORE, Dec. 12, 2024 /PRNewswire/ -- b.well Connected Health, the leading platform for unified consumer health experiences, announced today that Sara...
A Growing Number of Biopharmas Leverage Veeva Compass Patient to Improve Commercialization
Modern commercial data helps organizations find new patients and HCPs PLEASANTON, Calif., Dec. 12, 2024 /PRNewswire/ -- Veeva Systems (NYSE:...
Jack Topdjian Joins eMerge Americas as Advisor for Health and Biotechnology Innovation Hub
MIAMI, Dec. 12, 2024 /PRNewswire/ -- eMerge Americas, the premier global technology conference + expo shaping the future of tech,...
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
The convergence of rising US healthcare costs, growing medical tourism, and the increasing demand for seamless patient financial experiences has...
Dr. Christina Campbell and Dr. Bruce Phillips launch “Hack The Code” Program for Weight Management
This program offered by the healthcare professional duo provides a solution to weight management backed by insights through genetic testing ...
AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL(R)
CDMO's Cell and Gene Center of Excellence Achieves fifth commercial viral vector product approval, and second overall from FDA in...
Integra Partners Expands Partnership With DMEscripts
Integra Partners today announced the expansion of their relationship with DMEscripts through the Integra Partners Group Purchasing Organization (GPO). NEW...
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological SocietiesMarlborough, Massachusetts--(Newsfile Corp. - December 12, 2024) - Phio...
Sibannac, Inc. (SNNC) Nears Completion of PCAOB Audit Preparations, Plans SEC Filing
Scottsdale, Arizona--(Newsfile Corp. - December 12, 2024) - Sibannac, Inc. (OTC Pink: SNNC), a visionary in the corporate development sector,...
Lash Me NYC Celebrating Women’s Empowerment Through Premium Lash Services
The Brooklyn-based salon, with locations in Brooklyn Heights and Carroll Gardens, is proud to help women embrace the simple but...
Significant Positive Results with Jaguar Health’s Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for...
Dr. Amir Bajoghli Presents on Advancements in Dermal Fillers and Facial Danger Zones at Georgetown/MedStar Washington Hospital
MCLEAN, VA / ACCESSWIRE / December 12, 2024 / Dr. Amir Bajoghli recently had the honor of presenting a comprehensive...
Rancho BioSciences, LLC Awarded Great Place to Work(R) Certification for the Third Consecutive Year
Celebrating a Culture of Collaboration and a Mission to Save Lives Through Data SAN DIEGO, CALIFORNIA / ACCESSWIRE / December...
Cellev8 Nutrition Launches the First GLP1 Support Gummy With Clinically Tested Ingredients
CELLEV8 Launches First Post-GLP-1 Gummy Supplement: "SlimCell™" with Clinically Proven Ingredients to Compliment GLP-1 WELLINGTON, FL / ACCESSWIRE / December...
Haven House Luxury Sober Living Nominated for Best Luxury Sober Living 2024 in Los Angeles
LOS ANGELES, CA / ACCESSWIRE / December 12, 2024 / Haven House Luxury Sober Living is honored to announce its...
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial
Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing...
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth...
GAT Sport(R) Unveils Nitraflex(R) SPORT: The Next Evolution in Pre-Workout Power, Now Banned Substance-Tested and Certified by Informed Sport
GAT Sport®, a trailblazer in sports nutrition, is thrilled to announce the launch of Nitraflex® SPORT. Certified with Informed Sport,...